Cardiovascular adjustments to pulmonary vascular injury in dogs.
The hemodynamic effects of blood volume augmentation and mechanical ventilation (MV) with positive end-expiratory pressure (PEEP) were studied in nine Beagles anesthetized with halothane before and after thrombin-induced pulmonary hypertension. The effect of therapy with dopamine, norepinephrine with and without nitroglycerin (NTG), and intraaortic balloon pumping (IABP) were studied in a second series of six Beagles. Before thrombin, dextran (35 ml.kg-1) caused a significant increase in right and left ventricular end-diastolic and end-systolic volumes (RV and LVEDV, and RV and LVESV). However, RV and LV performance, as estimated by ejection fraction, was unchanged during volume loading and MV with PEEP when the pulmonary vasculature was intact. The response to volume loading and MV with PEEP was altered significantly once PVR had been increased with the administration of thrombin. Stroke volumes were decreased, and remained so, despite volume loading and MV with PEEP. LVEDV decreased without a decrease in LVEDP, indicating a decreased LV compliance. Dopamine and norepinephrine with and without NTG increased stroke volumes and RV ejection fraction in contrast to IABP. Assessment of LV performance, according to the Frank-Starling mechanism, requires a measure of end-diastolic volume when diffuse pulmonary vasoconstriction leads to RV distension and LV hypovolemia secondary to septal shift. Measurement of LV filling pressures can provide misleading values to estimate changes in LV volume in this setting. Measurement of ventricular volumes is required for optimal management of patients with severe acute respiratory failure and pulmonary hypertension.
D000818:Animals; D001810:Blood Volume; D004285:Dogs; D004298:Dopamine / Q000627:therapeutic use; D006439:Hemodynamics; D006976:Hypertension, Pulmonary / Q000503:physiopathology* / Q000628:therapy; D007423:Intra-Aortic Balloon Pumping; D008297:Male; D005996:Nitroglycerin / Q000627:therapeutic use; D009638:Norepinephrine / Q000627:therapeutic use; D011175:Positive-Pressure Respiration
D005996:Nitroglycerin; D004298:Dopamine; D009638:Norepinephrine